Sample composition | PBMC | Total CD19-/CD19+ | CD19- CD45RA enriched/CD19+ | CD19- CD45RA depleted/CD19+ |
---|---|---|---|---|
CD45 isoform expression (% of CD3+ cells) | CD45RA+ 32% | CD45RA+: 74% CD45RO+: 4.2% | CD45RA+: 0% CD45RO+: 54% | |
Rearrangement | ||||
BV11-BJ2.2 (138 bases) | + | + | - | + |
BV13-BJ2.3 (201 bases) | + | + | + | - |
BV16-BJ1.6 (86 bases) | + | + | - | + |
BV16-BJ2.5 (81 bases) | + | + | - | + |